NO163816C - Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater. - Google Patents
Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater.Info
- Publication number
- NO163816C NO163816C NO862427A NO862427A NO163816C NO 163816 C NO163816 C NO 163816C NO 862427 A NO862427 A NO 862427A NO 862427 A NO862427 A NO 862427A NO 163816 C NO163816 C NO 163816C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- new therapeutic
- piperazine derivatives
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21225/85A IT1190375B (it) | 1985-06-20 | 1985-06-20 | N-benzidrildiazacicloalchil-alcanilidi ad attivita' antianafilattica ed antibroncospastica |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO862427D0 NO862427D0 (no) | 1986-06-18 |
| NO862427L NO862427L (no) | 1986-12-22 |
| NO163816B NO163816B (no) | 1990-04-17 |
| NO163816C true NO163816C (no) | 1990-07-25 |
Family
ID=11178661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862427A NO163816C (no) | 1985-06-20 | 1986-06-18 | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4675319A (de) |
| EP (1) | EP0207901B1 (de) |
| JP (1) | JPS61293977A (de) |
| KR (1) | KR870000309A (de) |
| CN (1) | CN1011784B (de) |
| AR (1) | AR241591A1 (de) |
| AT (1) | ATE58729T1 (de) |
| AU (1) | AU592348B2 (de) |
| CA (1) | CA1269980A (de) |
| DE (1) | DE3675824D1 (de) |
| DK (1) | DK291186A (de) |
| ES (1) | ES8708218A1 (de) |
| FI (1) | FI862204A (de) |
| GR (1) | GR861391B (de) |
| HU (1) | HU198033B (de) |
| IL (1) | IL78804A (de) |
| IT (1) | IT1190375B (de) |
| NO (1) | NO163816C (de) |
| NZ (1) | NZ216547A (de) |
| PH (1) | PH22809A (de) |
| PT (1) | PT82810B (de) |
| SG (1) | SG7292G (de) |
| TN (1) | TNSN86090A1 (de) |
| ZA (1) | ZA863754B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0660160B2 (ja) * | 1985-12-13 | 1994-08-10 | テルモ株式会社 | アミド誘導体およびこれを含有する抗アレルギ−剤 |
| FR2601366B1 (fr) * | 1986-07-10 | 1988-11-25 | Andre Buzas | Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant. |
| US5028610A (en) * | 1987-03-18 | 1991-07-02 | Sankyo Company Limited | N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use |
| FR2614021B1 (fr) * | 1987-04-14 | 1991-03-01 | Andre Buzas | Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant |
| US4745191A (en) * | 1987-09-30 | 1988-05-17 | American Home Products Corporation | 1-((A-substituted phenyl-ω-substituted piperazinyl)alkenyl) cyclohexanol |
| AU658656B2 (en) * | 1991-07-19 | 1995-04-27 | Zeria Pharmaceutical Co., Ltd. | 4-phenylmethylpiperazine derivatives and their use as antiallergic and antihistaminic agents |
| KR19990010329A (ko) * | 1997-07-16 | 1999-02-18 | 레나르트 태퀴스트 | 실리콘 질화물 절삭 공구 재료 |
| AU753360B2 (en) | 1998-07-31 | 2002-10-17 | Nippon Soda Co., Ltd. | Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| KR100384241B1 (ko) * | 2000-10-31 | 2003-05-16 | (주) 기산테크 | 저활동성 플라즈마 이온 방전을 이용한 오존발생장치 |
| DE102006047617B4 (de) * | 2006-10-09 | 2008-11-27 | Clariant International Limited | Verfahren zur Herstellung basischer (Meth)acrylamide |
| DE102006047618B3 (de) * | 2006-10-09 | 2007-11-15 | Clariant International Limited | Verfahren zur Herstellung von Bisbenzoxazolen |
| DE102006047619B4 (de) * | 2006-10-09 | 2008-11-13 | Clariant International Limited | Verfahren zur Herstellung basischer Fettsäureamide |
| DE102006047620B4 (de) | 2006-10-09 | 2008-11-27 | Clariant International Limited | Verfahren zur Herstellung tertiärer Amide von Alkylphenylcarbonsäuren |
| US8101785B2 (en) * | 2006-10-09 | 2012-01-24 | Clariant Finance (Bvi) Limited | Method for producing fatty acid alkanol amides |
| KR101079459B1 (ko) * | 2007-09-14 | 2011-11-03 | 이화여자대학교 산학협력단 | 신규한 화합물, 이의 제조방법 및 이를 포함하는 통증억제용 조성물 |
| DE102008017219A1 (de) * | 2008-04-04 | 2009-10-08 | Clariant International Ltd. | Verfahren zur Herstellung von Amiden in Gegenwart von überhitztem Wasser |
| DE102008017214B4 (de) * | 2008-04-04 | 2012-02-16 | Clariant International Limited | Kontinuierliches Verfahren zur Herstellung von Fettsäurealkanolamiden |
| DE102008017213B4 (de) * | 2008-04-04 | 2012-08-09 | Clariant International Limited | Kontinuierliches Verfahren zur Herstellung von Amiden aliphatischer Hydroxycarbonsäuren |
| DE102008017218B4 (de) * | 2008-04-04 | 2011-09-22 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Amiden niederer aliphatischer Carbonsäuren |
| DE102008017217A1 (de) * | 2008-04-04 | 2009-10-08 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren |
| DE102008017215B4 (de) * | 2008-04-04 | 2012-08-09 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Amiden ethylenisch ungesättigter Carbonsäuren |
| DE102008017216B4 (de) * | 2008-04-04 | 2013-08-14 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden |
| CN101429164B (zh) * | 2008-11-14 | 2013-03-20 | 广西大学 | 左旋二苯甲基哌嗪衍生物及其制备方法 |
| DE102009031059A1 (de) | 2009-06-30 | 2011-01-05 | Clariant International Ltd. | Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen |
| DE102009042523B4 (de) | 2009-09-22 | 2012-02-16 | Clariant International Ltd. | Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen |
| DE102009042522A1 (de) | 2009-09-22 | 2011-04-07 | Clariant International Ltd. | Kontinuierliches Umesterungsverfahren |
| DE102010056564A1 (de) | 2010-12-30 | 2012-07-05 | Clariant International Limited | Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung |
| DE102010056565A1 (de) | 2010-12-30 | 2012-07-05 | Clariant International Ltd. | Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere |
| WO2017066705A1 (en) * | 2015-10-14 | 2017-04-20 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
| CN114621101A (zh) * | 2020-12-11 | 2022-06-14 | 李冰坚 | 一种3,5-二甲基-1,2-苯二胺二盐酸盐的精制方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3244718A (en) * | 1964-02-17 | 1966-04-05 | Biel John Hans | Piperazine derivatives |
| NL137318C (de) * | 1964-06-09 | |||
| DE2304154A1 (de) * | 1973-01-29 | 1974-08-01 | Ichthyol Ges Cordes Hermanni & | Verfahren zur herstellung von substituierten piperazin- bzw. homopiperazinderivaten |
| JPS5070389A (de) * | 1973-10-30 | 1975-06-11 | ||
| GB2056968A (en) * | 1979-08-21 | 1981-03-25 | Fujisawa Pharmaceutical Co | Piperazine derivative, processes for the preparation thereof and pharmaceutical composition comprising the same |
| US4411900A (en) * | 1980-01-03 | 1983-10-25 | Fujisawa Pharmaceutical Co., Ltd. | Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same |
| JPS59118765A (ja) * | 1982-12-24 | 1984-07-09 | Fujisawa Pharmaceut Co Ltd | ピペラジン誘導体 |
| GB8303946D0 (en) * | 1983-02-12 | 1983-03-16 | Recordati Chem Pharm | Antihypertensive n-piperazinylalkanoylanilides |
| GB8320701D0 (en) * | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
-
1985
- 1985-06-20 IT IT21225/85A patent/IT1190375B/it active
-
1986
- 1986-05-16 IL IL78804A patent/IL78804A/xx not_active IP Right Cessation
- 1986-05-20 ZA ZA863754A patent/ZA863754B/xx unknown
- 1986-05-26 FI FI862204A patent/FI862204A/fi not_active Application Discontinuation
- 1986-05-28 GR GR861391A patent/GR861391B/el unknown
- 1986-06-02 CA CA000510539A patent/CA1269980A/en not_active Expired - Fee Related
- 1986-06-09 US US06/871,858 patent/US4675319A/en not_active Expired - Fee Related
- 1986-06-12 JP JP61137260A patent/JPS61293977A/ja active Pending
- 1986-06-16 NZ NZ216547A patent/NZ216547A/xx unknown
- 1986-06-17 ES ES556145A patent/ES8708218A1/es not_active Expired
- 1986-06-18 TN TNTNSN86090A patent/TNSN86090A1/fr unknown
- 1986-06-18 PH PH33900A patent/PH22809A/en unknown
- 1986-06-18 NO NO862427A patent/NO163816C/no unknown
- 1986-06-19 KR KR1019860004899A patent/KR870000309A/ko not_active Application Discontinuation
- 1986-06-19 CN CN86105641A patent/CN1011784B/zh not_active Expired
- 1986-06-19 DE DE8686830172T patent/DE3675824D1/de not_active Expired - Fee Related
- 1986-06-19 EP EP86830172A patent/EP0207901B1/de not_active Expired - Lifetime
- 1986-06-19 AU AU58828/86A patent/AU592348B2/en not_active Ceased
- 1986-06-19 AT AT86830172T patent/ATE58729T1/de not_active IP Right Cessation
- 1986-06-19 HU HU862581A patent/HU198033B/hu not_active IP Right Cessation
- 1986-06-19 AR AR86304331A patent/AR241591A1/es active
- 1986-06-20 PT PT82810A patent/PT82810B/pt not_active IP Right Cessation
- 1986-06-20 DK DK291186A patent/DK291186A/da not_active Application Discontinuation
-
1992
- 1992-01-25 SG SG72/92A patent/SG7292G/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0207901A1 (de) | 1987-01-07 |
| KR870000309A (ko) | 1987-02-17 |
| DK291186A (da) | 1986-12-21 |
| CA1269980A (en) | 1990-06-05 |
| NO163816B (no) | 1990-04-17 |
| TNSN86090A1 (fr) | 1990-01-01 |
| FI862204A0 (fi) | 1986-05-26 |
| US4675319A (en) | 1987-06-23 |
| JPS61293977A (ja) | 1986-12-24 |
| IL78804A0 (en) | 1986-09-30 |
| CN86105641A (zh) | 1987-04-01 |
| SG7292G (en) | 1992-03-20 |
| HUT43837A (en) | 1987-12-28 |
| ATE58729T1 (de) | 1990-12-15 |
| CN1011784B (zh) | 1991-02-27 |
| PT82810B (pt) | 1988-04-21 |
| EP0207901B1 (de) | 1990-11-28 |
| DK291186D0 (da) | 1986-06-20 |
| PH22809A (en) | 1988-12-27 |
| NO862427L (no) | 1986-12-22 |
| ZA863754B (en) | 1987-01-28 |
| ES8708218A1 (es) | 1987-10-01 |
| NZ216547A (en) | 1989-11-28 |
| GR861391B (en) | 1986-09-16 |
| AR241591A1 (es) | 1992-09-30 |
| DE3675824D1 (de) | 1991-01-10 |
| AU592348B2 (en) | 1990-01-11 |
| NO862427D0 (no) | 1986-06-18 |
| HU198033B (en) | 1989-07-28 |
| PT82810A (en) | 1986-07-01 |
| ES556145A0 (es) | 1987-10-01 |
| IT1190375B (it) | 1988-02-16 |
| IT8521225A0 (it) | 1985-06-20 |
| AU5882886A (en) | 1986-12-24 |
| IL78804A (en) | 1991-12-15 |
| FI862204A (fi) | 1986-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163816C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater. | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO167384C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater. | |
| NO167142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO871879D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser. | |
| NO166362C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater. | |
| NO852885L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater. | |
| NO165023C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater. | |
| NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
| NO163486C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater. | |
| NO870998D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater. | |
| NO165545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO172490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| NO168108C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive adeninderivater | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO891024L (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktivekinolin- og acridinforbindelser. | |
| NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO165635C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater. |